# BONDLIDO
> **NDA215029** · New Drug Application · Sponsor: MEDRX USA · Approved 2025-09-24
## Drug
- **FDA Application Number:** NDA215029
- **Application type:** New Drug Application
- **Brand name:** BONDLIDO
- **Generic name:** LIDOCAINE
- **Active ingredients:** LIDOCAINE
- **Dosage form:** SYSTEM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** MEDRX USA
- **Manufacturer:** MEDRx USA, Inc.
- **First approval:** 2025-09-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215029)
---
*MORVS · CC0 1.0*